162 related articles for article (PubMed ID: 32759007)
1. Prostaglandin D
Gupta A; Chander Chiang K
Med Hypotheses; 2020 Oct; 143():110122. PubMed ID: 32759007
[TBL] [Abstract][Full Text] [Related]
2. Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.
Chiang KC; Rizk JG; Nelson DJ; Krishnamurti L; Subbian S; Imig JD; Khan I; Reddy ST; Gupta A
Expert Opin Ther Targets; 2022 Jan; 26(1):13-28. PubMed ID: 35068281
[TBL] [Abstract][Full Text] [Related]
3. Lymphopenia in COVID-19: Therapeutic opportunities.
Fathi N; Rezaei N
Cell Biol Int; 2020 Sep; 44(9):1792-1797. PubMed ID: 32458561
[TBL] [Abstract][Full Text] [Related]
4. Is COVID-19 more severe in older men?
Liang X
Postgrad Med J; 2020 Jul; 96(1137):426. PubMed ID: 32404490
[No Abstract] [Full Text] [Related]
5. COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
Dersch R; Wehrum T; Fähndrich S; Engelhardt M; Rauer S; Berger B
Mult Scler; 2020 Sep; 26(10):1264-1266. PubMed ID: 32762488
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients.
Monneret G; Cour M; Viel S; Venet F; Argaud L
Intensive Care Med; 2020 Sep; 46(9):1764-1765. PubMed ID: 32488343
[No Abstract] [Full Text] [Related]
7. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
[TBL] [Abstract][Full Text] [Related]
8. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2: a storm is raging.
Pedersen SF; Ho YC
J Clin Invest; 2020 May; 130(5):2202-2205. PubMed ID: 32217834
[TBL] [Abstract][Full Text] [Related]
10. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
Sacchi A; Grassi G; Bordoni V; Lorenzini P; Cimini E; Casetti R; Tartaglia E; Marchioni L; Petrosillo N; Palmieri F; D'Offizi G; Notari S; Tempestilli M; Capobianchi MR; Nicastri E; Maeurer M; Zumla A; Locatelli F; Antinori A; Ippolito G; Agrati C
Cell Death Dis; 2020 Oct; 11(10):921. PubMed ID: 33110074
[TBL] [Abstract][Full Text] [Related]
11. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.
Jeannet R; Daix T; Formento R; Feuillard J; François B
Intensive Care Med; 2020 Sep; 46(9):1769-1771. PubMed ID: 32514592
[No Abstract] [Full Text] [Related]
12. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
14. Lymphopenia during the COVID-19 infection: What it shows and what can be learned.
Tavakolpour S; Rakhshandehroo T; Wei EX; Rashidian M
Immunol Lett; 2020 Sep; 225():31-32. PubMed ID: 32569607
[No Abstract] [Full Text] [Related]
15. Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients.
Zhang Y; Wang X; Li X; Xi D; Mao R; Wu X; Cheng S; Sun X; Yi C; Ling Z; Ma L; Ning Q; Fang Y; Sun B; Wu D
Cell Mol Immunol; 2020 Aug; 17(8):878-880. PubMed ID: 32587367
[No Abstract] [Full Text] [Related]
16. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
17. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
18. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.
Zhao Q; Meng M; Kumar R; Wu Y; Huang J; Deng Y; Weng Z; Yang L
Int J Infect Dis; 2020 Jul; 96():131-135. PubMed ID: 32376308
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced endogenous production of prostaglandin D
Maric J; Ravindran A; Mazzurana L; Van Acker A; Rao A; Kokkinou E; Ekoff M; Thomas D; Fauland A; Nilsson G; Wheelock CE; Dahlén SE; Ferreirós N; Geisslinger G; Friberg D; Heinemann A; Konya V; Mjösberg J
J Allergy Clin Immunol; 2019 Jun; 143(6):2202-2214.e5. PubMed ID: 30578872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
